BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


February Archive 2004 - have your press release here?

Global Life Science Ventures announces lead investment into NeurogesX

APRICOT trial reveals promising therapeutic potential for the HIV/HCV co-morbid population

Pharmaceutical Promotional Alliances: co-promotion v co-marketing

Syngene - New InGenius12 System High Resolution Gel Documentation at a Low Price

CHI's Business Strategies and Alliance Management Congress - Early Registration

Biotech Tracker: Cystic Fibrosis Gene Therapy Results Not Impressive

Biotech Tracker: CAT-192 Moves Forward

Cyclacel to present at BIO CEO & Investor Conference

Synbiosis: Automated Colony Counting Accelerates Development of Novel Pneumococcal Vaccines

BioPortfolio: Pipeline Portfolio Congress, Asthma strategic intelligence resource.

DXS And Sangtec Molecular Diagnostics Announce Licensing Agreement Of Scorpions[Tm] Technology

BioTech Stock Report: Protein Design Labs

Affymetrix Announces Completion of Smallpox Array Set Developed with CDC 

QualityMetric Clinical Trials Consulting Team: Health status varies. Our standards don’t

Abingworth life sciences venture capital group appoints Michelle Doig

How America built its high-tech economy. Technology Transfer in the Life-Sciences

NextGen Sciences Ltd announced that it has been granted its third patent to protect the novel fluid dispensing system 

New from Grant - multi-function three-in-one 3D rotator

The Consortium for Post Genome Science 2nd Conference

New Report from PharmaPlus: HIV Pipelines & Deals 

Bionest Partners names new head of Medical Device Practice

Cambridge Antibody Technology (CAT) Grants Licence To Wyeth

Bionest Partners launches Medical Device Practice

SENTRX Selected as Drug Safety Partner by Praecis Pharmaceuticals Incorporated 

BioPortfolio: Auction of Laboratory Equipment, Cancer strategic intelligence resource.

Abingworth appoints Joe Anderson to manage quoted life science

Pharma License Exchange™ partners with Needle & Rosenberg PC

Inpharmatica announces ADME agreement with drug discovery company Cellzome

atugen AG announces siRNA therapeutics program

Progress in material sciences - Strength Through Shape

Cambridge Antibody Technology (CAT) Group plc announces first quarter financial results

Cambridge Antibody Technology (CAT) and Genzyme announce preliminary results from phase I/II trial of CAT-192 for scleroderma

Hepatitis C: Unmet need for treatment therapies leads to opportunities for Pharma companies

Newly introduced Grant-bio PCV combined all-in-one centrifuge-vortex mixers

Newly introduced Grant-bio PTR multi-function rotators from Grant Instruments

Biotech Tracker: Accelerated Viramidine Development

Oxford Biomedica Signs Lentivector Licensing Agreement With Merck & Co

Boehringer Ingelheim enters into multi-target drug discovery collaboration with Morphochem

Capsulution NanoScience AG: Innovative Technology Company Triples Turnover

DVC Deutsche Venture Capital further strengthens its position as leading European high tech investor

Sigma-Aldrich Voted #1 in Service and Support by Survey of International Life Scientists

Sigma-Aldrich Swiss Facilities Receive ISO 9001:2000 Re-Certification

New Appointments to JPK Instruments AG's Supervisory Board

Agilent Technologies Provides Whole Human Genome Microarray with Industry-Leading Sensitivity and Scanner Compatibility

PHARMA LICENSE EXCHANGE® pre-event information exchange, start date announced

Unique Cell-based Bioassay Services developed by SBH Sciences

Biotech Tracker: Immunomedics Antibody Moves Forward

BioTech Stock Report: Close Call - Adolor

CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC (CAT) 2004 ANNUAL GENERAL MEETING STATEMENT

EXONHIT THERAPEUTICS announces EURO 8.3 MILLION in fund to support clinical development 

Japanese pharmaceutical companies: Survival through improved R&D

ASINEX and Proteom Announce Successful BioScreening Project

 


BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.